NL-OMON52205尚未招募不适用
Treat-to-target in systemic lupus erythematosus: a pilot study - T2T-SLE
Amsterdam UMC0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •- Age 18 years or older
- •- Diagnosed with SLE according to the American College of Rheumatology (ACR)
- •revised criteria for the classification of SLE.
- •- Signed informed consent form
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •- Life-threatening SLE manifestations that require intensive care treatment
- •- Pregnancy or breastfeeding during the time period of the pilot study
研究者
相似试验
已完成
4 期
Evaluation of the contribution of lupus in the distribution of statins to the liver.Systemic lupus erythematosusRBR-6p37zrFaculdade de Ciências Farmacêuticas de Ribeirão Preto da Universidade de São Paulo
已完成
1 期
Omalizumab for LupusSystemic Lupus ErthematosusSjogren's SyndromeNCT01716312National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)17
撤回
1 期
A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or LupusSystemic Lupus ErythematosusNCT06238531National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
终止
2 期
TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )Lupus Erythematosus, SystemicLupus NephritisNCT00368264Medical University of Vienna1
招募中
不适用
LUPUS-BEST - Treat-to-target in Systemic Lupus ErythematosusSystemic Lupus ErythematosusNCT05714930Heinrich-Heine University, Duesseldorf606